Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Clinical trial NCT00309556 · COMPLETED
Trial details
- NCT number
- NCT00309556
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.